If thats the standard, then others should be allowed to improve and modify it too. I wonder if anyone in this thread (and I realize this is sort of a different issue but connected) has ever been almost bankrupted by the cost of medical care in the US
- April 23, 2025 - AM-PR The extensive body of research from Mayo Clinic emphasizes major advancements in obesity, including prediction of GLP-1 side effects, a new obesity sub-phenotype, and insights into personalized bariatric and endoscopic procedures
Maternal prepregnancy overweight and obesity and the risk of preeclampsia: a meta-analysis of cohort studies
Based on this assessment, no known safety concerns or ingredient interactions with GLP-1 medications were identified
Our experience led to a proof-of-concept study in the insulin-secreting pancreatic -cell line, MIN-6, and the GLP-1-secreting intestinal L-cell line, GLUTag
When semaglutide helps achieve meaningful weight reductiontypically 515% of body weight in clinical trialspatients experience improvements in blood pressure, cholesterol profiles, and inflammatory biomarkers
